Assessing depressive symptoms in multiple sclerosis: Is it necessary to omit items from the original beck depression inventory?

Journal of Behavioral Medicine

Volumn 22, Issue 2, 1999, Pages 127-142

  Aikens, J E ^a   Reinecke, M A ^b   Pliskin, N H ^b   Fischer, J S ^b   Wiebe, J S ^b   McCracken, L M ^b   Taylor, J L ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b NONE

Author keywords

Assessment; Beck Depression Inventory; Depression; Multiple sclerosis

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; SYMPTOMATOLOGY; WORK CAPACITY;

ADULT; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS;

EID: 0033046735     PISSN: 01607715     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018731415172     Document Type: Article

References (47)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition, American Psychiatric Association, Washington, DC.
2. Anastasi, A. (1988). Psychological Testing, 6th ed., Macmillan, New York.
3. Beck, A. T., and Steer, R. A., (1987). Manual for the Revised Beck Depression Inventory, Psychological Corporation, San Antonio, TX.
4. Beck, A. T., Steer, R. A., and Garbin, M. G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin. Psychol. Rev. 8: 77-100.
5. Beck, A. T., Steer, R. A., and Brown, G. K. (1996). The Beck Depression Inventory - II, Psychological Corporation, San Antonio, TX.
6. Cavanaugh, S., Clark, D. C., and Gibbons, R. D. (1983). Diagnosing depression in the hospitalized medically ill. Psychosomatics 24: 809-815.
7. Clark, D. C., Cavanaugh, S. V., and Gibbons, R. D. (1983). The core symptoms of depression in medical and psychiatric patients. J. Nerv. Ment. Dis. 173: 482-487.
8. Dobson, K. (1989). A meta-analysis of the efficacy of cognitive therapy for depression. J. Consult. Clin. Psychol. 57: 414-419.
9. Fava, M., and Rosenbaum, J. (1995). Pharmacotherapy and somatic therapies. In Beckham E., and Leber, W. (eds.), Handbook of Depression, 2nd ed., Guilford Press, New York, pp. 280-301.
10. Fawcett, J., Scheftner, W., Clark, D., Hedeker, D., Gibbons, R., and Coryell, W. (1987). Clinical predictors of suicide in patients with major affective disorders: A controlled prospective study. Am. J. Psychiatry 144: 35-40.
11. First, M. B., Spitzer, R. L., Gibbon, M., and Williams, J. B. W. (1995). Structured Clinical Interview for the DSM-IV Axis I Disorders - Patient Edition (SCID I/ P, Version 2.0), Biometrics Research Department, New York.
12. Fischer, J. S., Foley, F. W., Aikens, J. E., Ericson, G. D., Rao, S. M., and Schindell, S. S. (1994). What do we really know about cognitive dysfunction, affective disorders, and stress in multiple sclerosis? A practitioner's guide. J. Neurol. Rehab. 8: 151-64.
13. Geisser, M. E., Roth, R. S., and Robinson, M. E. (1997). Assessing depression among persons with chronic pain using the Center for Epidemiological Studies - Depression Scale and the Beck Depression Inventory: A comparative analysis. Clin. J. Pain 13: 153-170.
14. Isometsa, E. T., Aro, H. M., Henrikkson, M. M., Heikenen, M. E., and Lonnqvist, J. K. (1994). Suicide in major depression in different settings. J. Clin. Psychiatry 55: 523-527.
15. Hill, A. B., Kemp-Wheeler, and Jones, S. A. (1987). Subclinical and clinical depression: Are analogue studies justifiable? Person. Indiv. Diff. 8: 113-120.
16. Hollon, S., Shelton, R., and Davis, D. (1993). Cognitive therapy for depression: Conceptual issues and clinical efficacy. J. Consult. Clin. Psychol. 61: 270-275.
17. Huber, S. J., Rammohan, K. W., Bornstein, R. A., and Christy, J. A. (1993). Depressive symptoms are not influenced by severity of multiple sclerosis. Neuropsychiatry Neuropsychol. Behav. Neurol. 6: 177-180.
18. IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group (1995). Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology 45: 1277-1285.
19. Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., Alam, J. J., Bartoszak, D. M., Bourdette, D. N., Braiman, J., Brownscheidle, C. M., Coats, M. E., Cohan, S. L., Dougherty, D. S., Kinkel, R. P., Mass, M. K., Munschauer, F. E., 3rd, Priore, R. L., Pullicino, P. M., Scherokman, B. J., and Whitham, R. H. (1996). Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann. Neurol. 39: 285-294.
20. Joffe, R. T., Lippert, G. P., Gray, T. A., Sawa, G., and Horvath, Z. (1987). Mood disturbance and multiple sclerosis. Arch. Neurol. 44: 376-378.
21. Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., Vollmer, T., Weiner, L. P., Wolinsky, J. S., and the Copolymer 1 Multiple Sclerosis Study Group (1995). Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled study. Neurology 45: 1268-1276.
22. Johnson, S. K., DeLuca, J., and Natelson, B. H. (1996). Depression in fatiguing illness: comparing patients with chronic fatigue syndrome, multiple sclerosis and depression. J. Affect. Dis. 39: 21-30.
23. Klerman, G. (1987). Clinical epidemiology of suicide. J. Clin. Psychiatry 48: 33-38.
24. Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 1444-1452.
25. Lapp, W. M., and Collins, R. L. (1993). Relative / proportional scoring of the Ways of Coping Checklist: Is it advantageous or artifactual? Multivar. Behav. Res. 28: 483-512.
26. Lustman, P. J., Freedland, K. E., Carney, R. M., Hong, B. A., and Clouse, R. E. (1992). Similarity of depression in diabetic and psychiatric patients. Psychosom. Med. 54: 602-611.
27. Lustman, P. J., Clouse, R. E., Griffith, L. S., Carney, R. M., and K. E. Freedland, (1997). Screening for depression in diabetes using the Beck Depression Inventory. Psychosom. Med. 59(1): 24-31.
28. Mackenzie, T., and Popkin, M. (1990). Medical illness and suicide. In Blumenthal, S., and Kupfer, D. (eds.), Suicide Over the Life Cycle: Risk Factors, Assessment and Treatment of Suicidal Patients, American Psychiatric Press, Washington, DC, pp. 205-234.
29. Maguire, P., Hopwood, P., Tarrier, N., and Howell, T. (1985). Treatment of depression in cancer patients. Acta Psychiatr. Scand. 72 (Suppl. 320): 81-84.
30. Mohr, D. C., Goodkin, D. E., Likosky, W., Beutler, L., Gatto, N., and Langan, M. K. (1997). Identification of Beck Depression Inventory items related to multiple sclerosis. J. Behav. Med. 20: 407-414.
31. Moorey, S., and Greer, S. (1989). Adjuvant psychological therapy: A cognitive-behavioural therapy for patients with cancer. Behav. Psychother. 17: 177-190.
32. Novy, D. M., Nelson, D. V., Berry, L. A., and Averill, P. M. (1995). What does the Beck Depression Inventory measure in chronic pain? A reappraisal. Pain 61: 261-270.
33. Pokorny, A. (1964). Suicide rates in various psychiatric disorders. J. Nerv. Ment. Dis. 139: 499-506.
34. Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, S. A., Silberberg, D. H., and Tourtellotte, W. W. (1983). New diagnostic criteria for multiple sclerosis. Ann. Neurol. 13: 227-231.
35. Rao, S. M. (1986). Neuropsychology of multiple sclerosis: A critical review. J. Clin. Exp. Neuropsychol. 8: 503-542.
36. Robins, L. N., Helzer, J. E., Croughan, J., and Ratcliff, K. S. (1981). National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity. Arch. Gen. Psychiatry 38: 381-389.
37. Reck, J. R., Smith, T. W., Ward, J. R., and Milano, R. (1989). Disability and depression in rheumatoid arthritis: A multi-trait, multimethod investigation. Arth, Rheum. 32: 1100-1106.
38. Rudick, R., Goodkin, D., and Ransohoff, R. (1992). Pharmacotherapy of multiple sclerosis: Current status. Cleveland Clin. J. Med. 59: 267-277.
39. Rudick, R. A., Medendorp, S. V., Namey, M., Boyle, S., and Fischer, J. (1995). Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains. Multiple Sclerosis 1: 150-155.
40. Schiffer, R. (1987). The spectrum of depression in multiple sclerosis: An approach for clinical management. Arch. Neurol. 44: 596-599.
41. Sibley, W. A. (1990). The diagnosis and course of multiple sclerosis. In Rao, S. M. (ed.), Neurobehavioral Aspects of Multiple Sclerosis, Oxford University Press, New York, pp. 5-14.
42. Stenager, E. N., Stenager, E., Koch-Henriksen, N., et al. (1992). Suicide and multiple sclerosis: An epidemiological investigation. J. Neurol. Neurosurg. Psychiatry 55: 542-545.
43. Sullivan, M. J., Weinshenker, B., Mikail, S., and Bishop, S. R. (1995). Screening for major depression in the early stages of multiple sclerosis. Can. J. Neurol. Sci. 22: 228-231.
44. Vercoulen, J. H., Hommes, O. R., Swanink, C. M., Jongen, P. J., Fennis, J. F., Galama, J. M., van der Meer, J. W., and Bleijenberg G. (1996). The measurement of fatigue in patients with multiple sclerosis. A muftidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch. Neurol. 53: 642-649.
45. Weich, S. (1997). Prevention of the common mental disorders: A public health perspective. Psychol. Med. 27: 757-764.
46. Whitlock, F. (1986). Suicide and physical illness. In Roy, A. (ed.), Suicide, Williams & Wilkins, Baltimore.
47. Williams, A. C., and Richardson, P. H. (1993). What does the BDI measure in chronic pain? Pain 55: 259-266.